1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ADYNOVATE
  1. Approved Blood Products

ADYNOVATE

STN: BL 125566
Proper Name: Antihemophilic Factor (Recombinant) PEGylated
Tradename: ADYNOVATE
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
Indication:
TADYNOVATE, Antihemophilic Factor (Recombinant), PEGylated, is a human antihemophilic factor indicated in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to reduce the frequency of bleeding episodes.

Product Information

Supporting Documents

 

Back to Top